297 related articles for article (PubMed ID: 18707646)
1. Current status and future prospects for cell transplantation to prevent congestive heart failure.
Menasché P
Semin Thorac Cardiovasc Surg; 2008; 20(2):131-7. PubMed ID: 18707646
[TBL] [Abstract][Full Text] [Related]
2. Cardiac cell therapy trials: chronic myocardial infarction and congestive heart failure.
Menasché P
J Cardiovasc Transl Res; 2008 Sep; 1(3):201-6. PubMed ID: 20559920
[TBL] [Abstract][Full Text] [Related]
3. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy.
Memon IA; Sawa Y; Miyagawa S; Taketani S; Matsuda H
J Thorac Cardiovasc Surg; 2005 Sep; 130(3):646-53. PubMed ID: 16153908
[TBL] [Abstract][Full Text] [Related]
4. Skeletal myoblasts as a therapeutic agent.
Menasché P
Prog Cardiovasc Dis; 2007; 50(1):7-17. PubMed ID: 17631434
[TBL] [Abstract][Full Text] [Related]
5. Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy.
Eisen HJ
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):520-1. PubMed ID: 18648335
[TBL] [Abstract][Full Text] [Related]
6. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.
Menasché P; Alfieri O; Janssens S; McKenna W; Reichenspurner H; Trinquart L; Vilquin JT; Marolleau JP; Seymour B; Larghero J; Lake S; Chatellier G; Solomon S; Desnos M; Hagège AA
Circulation; 2008 Mar; 117(9):1189-200. PubMed ID: 18285565
[TBL] [Abstract][Full Text] [Related]
7. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure.
Bonaros N; Rauf R; Wolf D; Margreiter E; Tzankov A; Schlechta B; Kocher A; Ott H; Schachner T; Hering S; Bonatti J; Laufer G
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1321-8. PubMed ID: 17140950
[TBL] [Abstract][Full Text] [Related]
8. [Cardiac cell therapy: the puzzle is waiting to be solved].
Canepa M; Coviello D; Chiarella F
G Ital Cardiol (Rome); 2006 Apr; 7(4):252-65. PubMed ID: 16700408
[TBL] [Abstract][Full Text] [Related]
9. Postinfarction heart failure: surgical and trans-coronary-venous transplantation of autologous myoblasts.
Siminiak T; Burchardt P; Kurpisz M
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S46-51. PubMed ID: 16501631
[TBL] [Abstract][Full Text] [Related]
10. Myocardial repair with autologous skeletal myoblasts: a review of the clinical studies and problems.
Smits PC
Minerva Cardioangiol; 2004 Dec; 52(6):525-35. PubMed ID: 15729213
[TBL] [Abstract][Full Text] [Related]
11. Cell therapy for heart failure--muscle, bone marrow, blood, and cardiac-derived stem cells.
Ott HC; Davis BH; Taylor DA
Semin Thorac Cardiovasc Surg; 2005; 17(4):348-60. PubMed ID: 16428043
[TBL] [Abstract][Full Text] [Related]
12. [Myoblast transplantation for heart failure: where are we heading?].
Menasché P; Hagège AA; Desnos M
Arch Mal Coeur Vaiss; 2005 Jun; 98(6):649-54. PubMed ID: 16007819
[TBL] [Abstract][Full Text] [Related]
13. Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure.
McConnell PI; del Rio CL; Jacoby DB; Pavlicova M; Kwiatkowski P; Zawadzka A; Dinsmore JH; Astra L; Wisel S; Michler RE
J Thorac Cardiovasc Surg; 2005 Oct; 130(4):1001. PubMed ID: 16214511
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblasts in the treatment of post-infarction myocardial contractility impairment: the POZNAN trial.
Siminiak T; Fiszer D; Jerzykowska O; Grygielska B; Rozwadowska N; Kałmucki P; Kurpisz M
Eur Heart J; 2005 Jun; 26(12):1188-95. PubMed ID: 15764613
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells.
Zenovich AG; Davis BH; Taylor DA
Handb Exp Pharmacol; 2007; (180):117-65. PubMed ID: 17554507
[TBL] [Abstract][Full Text] [Related]
16. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.
Siminiak T; Kalawski R; Fiszer D; Jerzykowska O; Rzeźniczak J; Rozwadowska N; Kurpisz M
Am Heart J; 2004 Sep; 148(3):531-7. PubMed ID: 15389244
[TBL] [Abstract][Full Text] [Related]
17. Cell-based therapy for heart failure: skeletal myoblasts.
Seidel M; Borczyńska A; Rozwadowska N; Kurpisz M
Cell Transplant; 2009; 18(7):695-707. PubMed ID: 19500482
[TBL] [Abstract][Full Text] [Related]
18. Stem cells for clinical use in cardiovascular medicine: current limitations and future perspectives.
Menasché P
Thromb Haemost; 2005 Oct; 94(4):697-701. PubMed ID: 16270619
[TBL] [Abstract][Full Text] [Related]
19. Advances in cell-based therapy for structural heart disease.
Mazhari R; Hare JM
Prog Cardiovasc Dis; 2007; 49(6):387-95. PubMed ID: 17498519
[TBL] [Abstract][Full Text] [Related]
20. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
Schannwell CM
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
